From Strategy to Success: Unlock Access, Maximize Growth

Helping leaders secure access, maximize value, and drive sustained success.

Biopharmaceutical & MedTech Market Access | HEOR Strategy

Securing market access in biopharma, MedTech, and health-focused industries isn’t easy. Complex regulations, shifting payer expectations, and competitive pressure can derail even the strongest products. Success requires more than innovation—it demands a strategy that aligns with market realities.

That’s where I come in—helping companies navigate these challenges to maximize access, value, and long-term growth.

Expertise in Market Access & HEOR

With a track record of driving market access for leading companies, I deliver comprehensive strategies that align innovation with payer expectations and healthcare system demands. My approach integrates HEOR—demonstrating clinical, economic, and patient value—along with economic modeling, real-world evidence, and stakeholder engagement to create strategies that not only open doors but also position products for sustained success in competitive markets.

Expertise Across Industries

Focused on biopharma and MedTech, with expertise that extends to industries where market access, pricing, and value demonstration are critical:

Biopharmaceuticals • MedTech • Medical Devices • Digital Health & Health Tech • Diagnostics (Companion and Standalone) • Specialty Pharmacy & Pharmaceutical Benefit Management (PBMs) • Gene and Cell Therapies • Veterinary Pharmaceuticals & Animal Health • Medical Nutrition & Functional Foods • Consumer Health Products (OTC) • Nutraceuticals • Biotech Agriculture • Regulated Medical Cannabis

Areas of Expertise

  • Pricing, Access & Reimbursement Strategy

    Developing competitive pricing models that maximize reimbursement.

    Designing risk-sharing and value-based agreements with payers.

    Building dynamic pricing strategies that adapt to market shifts.

  • HEOR & Real-World Evidence (RWE)

    Conducting health economic and cost-effectiveness modeling.

    Using real-world data to strengthen product value cases.

    Supporting payer acceptance with patient-reported outcomes.

  • Global Market Expansion & Commercial Strategy

    Crafting market entry and growth strategies for new regions.

    Navigating complex regulatory and reimbursement landscapes.

    Leveraging early access programs to accelerate adoption.

  • Stakeholder & Payer Engagement

    Creating evidence-based value propositions for payers.

    Leading advisory board discussions and negotiations.

    Aligning product value with healthcare system priorities.

  • Regulatory & Policy Navigation

    Anticipating policy changes and adapting market strategies.

    Providing insights on reimbursement and HTA requirements.

    Minimizing access barriers and ensuring market longevity.

  • Innovative Contracting & Market Access Execution

    Designing outcome-based reimbursement and risk-sharing models.

    Structuring managed entry agreements with evolving payers.

    Ensuring execution through market feedback and coordination.

Schedule a Consultation